在自身免疫血液溶解性贫血中与骨髓反应不充分的重组性红色素:一个前性分析
Bruno Fattizzo1,2, Giacinto Luca Pedone1,2, Caterina Brambilla1,2
1Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Blood advances
|November 29, 2023
概括
复合性红色素 (rEPO) 有效地治疗自身免疫血液溶解性贫血 (AIHA) 患者的骨髓反应较差. 这种疗法改善了血红蛋白水平,减少了输血需求,为标准治疗提供了安全的补充.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 自身免疫血液溶解性贫血 (AIHA) 可能呈现骨髓 (BM) 反应不足,其特征是网红细胞和红色素的低水平.
- 这种不有效的BM补偿与严重的贫血,增加输血需求和住院治疗有关.
研究的目的:
- 在AIHA患者中前性地评估复合性红色素 (rEPO) 的疗效和安全性,这些患者的BM补偿不足.
主要方法:
- 47名AIHA患者的队列接受皮下阿尔法乙 (40,000 IU/周) 直到血红蛋白 (Hb) >11 g/dL,然后逐渐减少.
- 同时使用的药物被记录下来,并对与rEPO相关的不良事件的安全性进行了监测.
主要成果:
- 观察到高响应率:55%在15天,达到91%在12个月.
- 发现了显著的Hb增加,在12个月后的中位数增加为+4.4g/dL.
- 治疗后的输血需求从30%降至10%以下. 没有发生与rEPO相关的严重不良事件.
结论:
- 对于AIHA患者,rEPO是一种安全有效的补充疗法,骨髓补偿不足.
- rEPO显著提高了血红蛋白水平,并减少了这一患者群体的输血依赖.
- 这项研究支持rEPO在标准免疫抑制不足时管理AIHA的作用.
更多相关视频
相关概念视频
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


